-
June 2026: This Month in Huntington’s Disease Research
Latest News
-
A DNA repair protein modifies the stability of long CAG tracts in the Huntington's disease gene
DNA repair is a critical process to cells, but errors in this process might explain 'repeat instability' in HD
-
Landmark study puts Huntington's disease trials on TRACK
Final results from the TRACK-HD study show very specific changes in HD. We're ready for trials: bring on the drugs!
-
Splicing with danger: a new way of thinking about the harmful Huntington's disease protein
Researchers discover a new way harmful fragments of the huntingtin protein are made in neurons.
-
Proposed Huntington's disease 'biomarker' is not useful, new study suggests
New study shows a blood chemical called '8OHdG' is not a good biomarker for HD. Bad news?
-
Is access to predictive genetic testing for Huntington's disease a problem?
Is access to predictive genetic testing for Huntington's disease a problem? A UBC study says it is.
-
HD Therapeutics Conference 2013 Updates: Day 3
Final day of our coverage of the Huntington's Disease Therapeutics Conference 2013
-
HD Therapeutics Conference 2013 Updates: Day 2
Day 2 of our coverage of the Huntington's Disease Therapeutics Conference
-
Major Roche-Isis deal boosts Huntington's disease gene silencing
'ASO' gene silencing drugs for HD boosted by major deal between Isis Pharmaceuticals and Roche
-
HD Therapeutics Conference 2013 Updates: Day 1
Day 1 of our coverage of the Huntington's Disease Therapeutics Conference
-
Lost in translation? New insights into the making of the Huntington's disease protein
Production of normal-length & extra-long huntingtin is controlled differently. A new way to keep cells healthy in HD?
HDBuzz Trial Tracker
Sites for Phase 3 trial for votoplam, INVEST-HD, now open. Updates on recruitment and first dosing imminent.
REGEN4HD, Phase 1 stem cell implantation study commences
Progress update for NCT06585449 – A Study to Evaluate ALN-HTT02
